K. Basile

发表

An emergent clade of SARS-CoV-2 linked to returned travellers from Iran

E. Holmes, T. Sorrell, V. Sintchenko, 2020, bioRxiv.

Accuracy amidst ambiguity: false positive SARS-CoV-2 nucleic acid tests when COVID-19 prevalence is low

J. Kok, S. Maddocks, K. Basile, 2020, Pathology.

SARS-CoV-2 Within-Host and in vitro Genomic Variability and Sub-Genomic RNA Levels Indicate Differences in Viral Expression Between Clinical Cohorts and in vitro Culture

V. Sintchenko, C. Lam, J. Kok, 2022, Frontiers in Microbiology.

Fungal Infections Other Than Invasive Aspergillosis in COVID-19 Patients

J. Kok, S. Chen, C. Halliday, 2022, Journal of fungi.

Simultaneous co-detection of wild-type and vaccine strain measles virus using the BD MAX system.

D. Dwyer, J. Kok, Kiran Thapa, 2018, Pathology.

Fat and flu: fact or fiction?

D. Dwyer, J. Kok, K. Basile, 2016 .

SARS-CoV-2 Genome Sequencing Methods Differ in Their Abilities To Detect Variants from Low-Viral-Load Samples

V. Sintchenko, C. Lam, J. Kok, 2021, Journal of clinical microbiology.

The Antibody Response to SARS-CoV-2 Infection

V. Sintchenko, M. O’Sullivan, D. Dwyer, 2020, Open forum infectious diseases.

DIFFER IN THEIR ABILITY TO 1 DETECT VARIANTS FROM LOW VIRAL LOAD SAMPLES 2

V. Sintchenko, C. Lam, D. Dwyer, 2021 .

Cell-based culture of SARS-CoV-2 informs infectivity and safe de-isolation assessments during COVID-19

V. Sintchenko, Dominic Michael Dwyer, M. O’Sullivan, 2020, medRxiv.

Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine

V. Sintchenko, C. Lam, D. Dwyer, 2022, Viruses.

Improved neutralization of the SARS-CoV-2 Omicron variant after Pfizer-BioNTech BNT162b2 COVID-19 vaccine boosting

V. Sintchenko, C. Lam, D. Dwyer, 2021 .

Seroepidemiology of Parechovirus A3 Neutralizing Antibodies, Australia, the Netherlands, and United States

R. Selvarangan, D. Pajkrt, M. D. de Jong, 2019, Emerging infectious diseases.

of SARS-CoV-2 informs infectivity and safe de-isolation assessments during COVID-19

V. Sintchenko, M. O’Sullivan, D. Dwyer, 2020 .

Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling

Mikhail Prokopenko, Rosemarie Sadsad, Edward C. Holmes, 2020, Nature Medicine.

Revealing COVID-19 Transmission by SARS-CoV-2 Genome Sequencing and Agent Based Modelling

M. Prokopenko, E. Holmes, T. Sorrell, 2020, bioRxiv.

Laboratory diagnosis of severe acute respiratory syndrome coronavirus 2

J. Kok, W. Rawlinson, S. Chen, 2020, Pathology.

RESISTANCE CONFERRING MUTATIONS IN SARS-CoV-2 DELTA FOLLOWING SOTROVIMAB INFUSION

V. Sintchenko, D. Dwyer, J. Kok, 2021, medRxiv.

Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use

V. Sintchenko, D. Dwyer, J. Kok, 2022, The New England journal of medicine.

Arthropod-Borne Flaviviruses in Pregnancy

D. Dwyer, J. Kok, S. Maddocks, 2023, Microorganisms.

SARS-CoV-2 within-host and in-vitro genomic variability and sub-genomic RNA levels indicate differences in viral expression between clinical and in-vitro cohorts.

V. Sintchenko, C. Lam, J. Kok, 2021, medRxiv.

An emergent clade of SARS-CoV-2 linked to returned travellers from Iran

E. Holmes, T. Sorrell, V. Sintchenko, 2020, bioRxiv.

Improved neutralisation of the SARS-CoV-2 Omicron variant after Pfizer-BioNTech (BNT162b2) COVID-19 vaccine boosting with a third dose

V. Sintchenko, C. Lam, M. O’Sullivan, 2021, bioRxiv.

Point-of-care diagnostics for respiratory viral infections

D. Dwyer, J. Kok, K. Basile, 2017, Expert review of molecular diagnostics.

Cell-based Culture Informs Infectivity and Safe De-Isolation Assessments in Patients with Coronavirus Disease 2019

V. Sintchenko, M. O’Sullivan, D. Dwyer, 2020, Clinical Infectious Diseases.

The impact of influenza virus infection in pregnancy.

D. Dwyer, J. Kok, K. Basile, 2018, Future microbiology.

Prolonged PCR positivity in elderly patients infected with SARS-CoV-2

D. Dwyer, J. Kok, S. Maddocks, 2021, Pathology.

Zika virus: what, where from and where to?

D. Dwyer, J. Kok, K. Basile, 2017, Pathology.

Fulminant Bacillus cereus food poisoning with fatal multi-organ failure

P. Ferguson, C. Colaco, Jenny L. Draper, 2021, BMJ Case Reports.

Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus

V. Sintchenko, J. Kok, John-Sebastian Eden, 2020, Journal of Clinical Virology.

SARS-CoV-2 Genome Sequencing Methods Differ In Their Ability To Detect Variants From Low Viral Load Samples

V. Sintchenko, C. Lam, D. Dwyer, 2021, bioRxiv.

Response

V. Sintchenko, John-Sebastian Eden, S. Maddocks, 2020, Journal of Clinical Virology.

Response to correspondence received on our paper:Interpret with caution: an evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus

V. Sintchenko, J. Kok, John-Sebastian Eden, 2020, Journal of Clinical Virology.

Emergent Omicron BR.2.1 sublineage of SARS-CoV-2 in New South Wales, Australia: a subvariant with high fitness but without increased disease severity

V. Sintchenko, D. Dwyer, J. Kok, 2023, International Journal of Infectious Diseases.

A laboratory framework for ongoing optimisation of amplification based genomic surveillance programs

V. Sintchenko, C. Lam, C. Suster, 2023, bioRxiv.

Improved neutralisation of the SARS-CoV-2 Omicron variant after Pfizer-BioNTech (BNT162b2) COVID-19 vaccine boosting with a third dose

V. Sintchenko, Dominic Michael Dwyer, C. Lam, 2021, bioRxiv.

Genomic evolution of SARS-CoV-2 variants of concern under in vitro neutralising selection pressure following two doses of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine

V. Sintchenko, C. Lam, R. Rockett, 2023, bioRxiv.

Advancing pathogen genomics in resource-limited settings

V. Sintchenko, O. Sessions, Eby M. Sim, 2023, Cell genomics.